Skip to content

Psychedelic Ethics

Daniel Villiger

Philosophy Compass September 1, 2025 DOI: 10.1111/phc3.70059 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Theoretical or philosophical paper Peer reviewed
Key points Argues that psychedelic ethics has become a thriving area within bioethics essential for grounding clinical developments in robust ethical reflection.

Abstract

ABSTRACT The reemergence of serotonergic psychedelics in clinical research and practice has sparked numerous debates within bioethics. This paper aims to provide an overview of the key issues discussed in the emerging field of psychedelic ethics. It organizes these issues into four (partly overlapping) categories: (1) the implementation and execution of psychedelic research and practice, (2) the ethics of belief as applied to PAT, (3) discrimination and injustice in psychedelic research and practice, and (4) potential consequences arising from the expansion of psychedelic research and a possible future approval of PAT. Overall, the paper shows that in just a few years, psychedelic ethics has become a thriving area within bioethics—one that is essential for grounding the rapid clinical developments in robust ethical reflection.